183 related articles for article (PubMed ID: 32459333)
1. Predominant Stroma-Rich Feature in Hyaline Vascular Variant of Castleman Disease Is Associated With Paraneoplastic Pemphigus.
Wang L; Nong L; Li F; Wang X; Wang R; Chen X; Tu P; Dong Y; Li T; Zhu X; Wang M
Am J Clin Pathol; 2020 Aug; 154(3):403-413. PubMed ID: 32459333
[TBL] [Abstract][Full Text] [Related]
2. Clinical and laboratory characterization of 114 cases of Castleman disease patients from a single centre: paraneoplastic pemphigus is an unfavourable prognostic factor.
Dong Y; Wang M; Nong L; Wang L; Cen X; Liu W; Zhu S; Sun Y; Liang Z; Li Y; Ou J; Qiu Z; Ren H
Br J Haematol; 2015 Jun; 169(6):834-42. PubMed ID: 25824806
[TBL] [Abstract][Full Text] [Related]
3. Unicentric Castleman disease, hyaline vascular variant, stromal rich, with increased plasma cells and a high level of serum IL-6: Raising the diagnostic and therapeutic issues.
Lyapichev KA; Sukswai N; Strati P; Iyer SP; Medeiros LJ; Miranda RN
Ann Diagn Pathol; 2019 Dec; 43():151398. PubMed ID: 31630065
[No Abstract] [Full Text] [Related]
4. Paraneoplastic pemphigus associated with Castleman disease: A multicenter case series.
Barry KK; Plumptre I; Bazewicz CG; Green BP; Treat JR; Hughes M; Morel KD; Wiss K; Liang MG
Pediatr Dermatol; 2023 Jan; 40(1):90-95. PubMed ID: 36128651
[TBL] [Abstract][Full Text] [Related]
5. Castleman disease and paraneoplastic pemphigus in a pregnant woman: A case report.
Cui B; Lin H
Medicine (Baltimore); 2021 Apr; 100(13):e24990. PubMed ID: 33787583
[TBL] [Abstract][Full Text] [Related]
6. [Surgical treatment and prognosis analysis of localized retroperitoneal Castleman disease: a study of 20 cases].
Tang JQ; Yang YM; Xiong Y; Wan YL; Zhu XJ
Zhonghua Wai Ke Za Zhi; 2009 Nov; 47(22):1685-8. PubMed ID: 20137716
[TBL] [Abstract][Full Text] [Related]
7. Paraneoplastic pemphigus uncovers distinct clinical and biological phenotypes of western unicentric Castleman disease.
Dieudonné Y; Silvestrini MA; Dossier A; Meignin V; Jouenne F; Mahévas T; Bouaziz JD; Jackson MA; Mordant P; Poirot J; Onodi F; Calvani J; Hourseau M; Evrard D; Berisha M; Perrin F; Danel C; Borie R; Galicier L; Mourah S; Bengoufa D; Oksenhendler E; Grootenboer-Mignot S; Boutboul D
Br J Haematol; 2023 Jul; 202(2):267-278. PubMed ID: 37221131
[TBL] [Abstract][Full Text] [Related]
8. Clinical characteristics and prognosis of patients with Castleman disease in a Chinese hospital: paraneoplastic pemphigus is an independent risk factor.
Hua Y; Liang C; Yang J; Wang L; Xu A; Xi L; Wang S; Wang Z
Am J Transl Res; 2022; 14(2):1051-1059. PubMed ID: 35273707
[TBL] [Abstract][Full Text] [Related]
9. Clinical Analysis of Unicentric Castleman's Disease with Paraneoplastic Pemphigus and Bronchiolitis Obliterans.
Zhen JF; Zhang L; Cao XX; Feng J; Zhou DB; Lin SB; Li J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Aug; 39(4):492-498. PubMed ID: 28877826
[TBL] [Abstract][Full Text] [Related]
10. Clinical and laboratory characterization of a large cohort of patients with Castleman disease retrospectively collected from a single center.
Dong Y; Na J; Lv J; Wang R; Chen X; Li N; Ren H
Leuk Lymphoma; 2009 Aug; 50(8):1308-17. PubMed ID: 19579073
[TBL] [Abstract][Full Text] [Related]
11. Masked pemphigus among pediatric patients with Castleman's disease.
Han SP; Fu LS; Chen LJ
Int J Rheum Dis; 2019 Jan; 22(1):121-131. PubMed ID: 30411519
[TBL] [Abstract][Full Text] [Related]
12. Retroperitoneal Castlemans disease associated with paraneoplastic pemphigus.
Choh NA; Qayoom S; Shaheen F; Malik RA; Rabbani I; Gojwari T
Hematol Oncol Stem Cell Ther; 2014 Jun; 7(2):93-6. PubMed ID: 24333134
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors of paraneoplastic pemphigus.
Leger S; Picard D; Ingen-Housz-Oro S; Arnault JP; Aubin F; Carsuzaa F; Chaumentin G; Chevrant-Breton J; Chosidow O; Crickx B; D'incan M; Dandurand M; Debarbieux S; Delaporte E; Dereure O; Doutre MS; Guillet G; Jullien D; Kupfer I; Lacour JP; Leonard F; Lok C; Machet L; Martin L; Paul C; Pignon JM; Robert C; Thomas L; Weiller PJ; Ferranti V; Gilbert D; Courville P; Houivet E; Benichou J; Joly P
Arch Dermatol; 2012 Oct; 148(10):1165-72. PubMed ID: 22801794
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for death and survival in paraneoplastic pemphigus associated with hematologic malignancies in adults.
Ouedraogo E; Gottlieb J; de Masson A; Lepelletier C; Jachiet M; Salle de Chou C; Galicier L; Bagot M; Chevret S; Bouaziz JD
J Am Acad Dermatol; 2019 Jun; 80(6):1544-1549. PubMed ID: 30981429
[TBL] [Abstract][Full Text] [Related]
15. Paraneoplastic pemphigus associated with Castleman tumor, myasthenia gravis and bronchiolitis obliterans.
Chorzelski T; Hashimoto T; Maciejewska B; Amagai M; Anhalt GJ; Jablonska S
J Am Acad Dermatol; 1999 Sep; 41(3 Pt 1):393-400. PubMed ID: 10459112
[TBL] [Abstract][Full Text] [Related]
16. Paraneoplastic pemphigus associated with follicular dendritic cell sarcoma arising from Castleman's tumor.
Lee IJ; Kim SC; Kim HS; Bang D; Yang WI; Jung WH; Chi HS
J Am Acad Dermatol; 1999 Feb; 40(2 Pt 2):294-7. PubMed ID: 10025851
[TBL] [Abstract][Full Text] [Related]
17. Whole-Exome Sequencing Reveals the Genomic Profile and IL6ST Variants as a Prognostic Biomarker of Paraneoplastic Pemphigus-Associated Unicentric Castleman Disease.
Wang S; Wang R; Shang P; Zhu X; Chen X; Zhang G; Wang M
J Invest Dermatol; 2024 Mar; 144(3):585-592.e1. PubMed ID: 37839777
[TBL] [Abstract][Full Text] [Related]
18. A critical role of surgery in the treatment for paraneoplastic pemphigus caused by localized Castleman's disease.
Fang Y; Zhao L; Yan F; Cui X; Xia Y; Duren A
Med Oncol; 2010 Sep; 27(3):907-11. PubMed ID: 19763912
[TBL] [Abstract][Full Text] [Related]
19. Paraneoplastic pemphigus: a case of long-term survival associated with systemic lupus erythematosus and polymyositis.
Mascaró JM; Ferrando J; Solé MT; Alsina M; Nousari HC; Anhalt GJ; Font J; Mascaró JM
Dermatology; 1999; 199(1):63-6. PubMed ID: 10449962
[TBL] [Abstract][Full Text] [Related]
20. [The clinical and pathological subtypes of Castleman's disease and their relationship with complications: a large series analysis from a single center].
Dong YJ; Wang RG; Chen XX; Na J; Lu JC; Li N; Xu WL; Ren HY
Zhonghua Xue Ye Xue Za Zhi; 2009 Apr; 30(4):255-9. PubMed ID: 19731827
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
